Status:
RECRUITING
Virtual Reality Therapy for Voice Hearing (VR-VOICES): a Randomized Controlled Trial
Lead Sponsor:
University Medical Center Groningen
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
Conditions:
Hallucinations, Verbal Auditory
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Rationale: Auditory verbal hallucinations (AVH) - hearing voices that others cannot hear - are common in mental illnesses. For many people AVH are distressing, disabling and persistent, despite medica...
Detailed Description
Study design: Single-blind randomized controlled intervention trial (RCT) with two arms: VR-VOICES as intervention and treatment as usual (TAU) as a control condition. Study population: Patients with...
Eligibility Criteria
Inclusion
- Having a DSM-5 diagnosis of a psychiatric disorder
- Distressing AVH for minimally 3 months.
- Age 16 years or older
Exclusion
- Insufficient command of the Dutch language
- Unable to provide informed consent
- Primary diagnosis of a substance use disorder, or organic brain disease (such as dementia)
- A degree of substance abuse that hinders treatment adherence
- Auditory verbal hallucinations in a language not spoken by therapists
- Patients cannot receive CBT specifically focused at gaining empowerment over voices during the study period or 6 months prior to enrolment.
Key Trial Info
Start Date :
October 31 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
112 Patients enrolled
Trial Details
Trial ID
NCT06013748
Start Date
October 31 2022
End Date
February 1 2026
Last Update
September 10 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Lentis
Groningen, Provincie Groningen, Netherlands
2
GGZ Drenthe
Assen, Netherlands
3
University Medical Center Groningen
Groningen, Netherlands, 9712EW